Isolation of glucagon‐37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno‐ileum
- 6 September 1982
- journal article
- Published by Wiley in FEBS Letters
- Vol. 146 (1) , 79-86
- https://doi.org/10.1016/0014-5793(82)80709-6
Abstract
A peptide isolated from porcine gut according to its glucagon-like activity in liver (bioactive enteroglucagon) has been characterized immunologically, biologically and chemically: its potency relative to pancreatic glucagon in interacting with an antiglucagon antibody, hepatic glucagon-binding sites and hepatic adenylate cyclase was ∼100%, 20% and 10%, respectively. In contrast, it is ∼20-times more potent than glucagon in oxyntic glands, justifying the term ‘oxyntomodulin’. Chemically, it consists in the 29 amino acid-peptide glucagon elongated at its C-terminal end by the octapeptide Lys—Arg—Asn—Lys—Asn—Asn—Ile &—Ala; accordingly, it is called ‘glucagon-37Keywords
This publication has 19 references indexed in Scilit:
- Isolation of glucagon‐37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno‐ileumFEBS Letters, 1982
- The primary structure of porcine glicentin (proglucagon)Regulatory Peptides, 1981
- ‘Enteroglucagon’: A specific effect on gastric glands isolated from the rat fundus. Evidence for an ‘oxyntomodulin’ actionBioscience Reports, 1981
- Bioactive enteroglucagon (oxyntomodulin): Present knowledge on its chemical structure and its biological activitiesPeptides, 1981
- N‐terminally extended somatostatin: The primary structure of somatostatin‐28FEBS Letters, 1980
- The preparation of deslysylalanyl porcine and bovine insulinsFEBS Letters, 1975
- Sequence DeterminationPublished by Springer Nature ,1975
- Gut glucagon: A common receptor site with pancreatic glucagon in liver cell plasma membranesFEBS Letters, 1973
- INCREASED GUT GLUCAGON RELEASE AS PATHOGENETIC FACTOR IN REACTIVE HYPOGLYCÆMIA?The Lancet, 1973
- Rapid sequence analysis of small peptidesAnalytical Biochemistry, 1970